Guangzhou Vbio-Pharma Co., Ltd.

Vbio-Pharma specializes in the R&D and manufacturing of APIs and their pharmaceutical preparations for animal reproduction. It is a high-tech biopharmaceutical company with the joint venture of capitals from China and Canada. It has its own R&D capability, GMP manufacturing facility and sales networking throughout China. The management team has established technology platforms for scale-up purification of native proteins and for production of long-acting recombinant proteins.

APIs include PMSG, HCG and GnRH. In fact, the PMSG API quality of internal control complies with the EP, with efficacy exceeding that of EP requirement. The API qualities of HCG and GnRH comply with human CP requirements. For the innovative drug, long-acting recombinant FSH is made by scale-up cell production through bioreactor and protein purification.

Pharmaceutical preparations include 优蕴康®（PMSG）、好韵宝®（HCG）、蕴立得®（GnRH） and 利生舒®（PGc）.

Our products have been widely used for reproduction of various animals, such as sows, dairy cows and sheep.  They can significantly improve estrus rate and conception rate when used for inducing estrus, timed artificial insemination and batch production in the animals mentioned above. In addition, The HCG can be utilized to promote ovulation in fishes.

VBio has been honored the No. 1 Brand for animal reproduction field in China.